Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1/2 × Has announcements × Plasma cell × Clear all

Phase

Phase 3 14 Phase 2 8 Phase 1/2 2 Phase 1 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 11 Thoracic 9 Other hematologic neoplasm 9 Gastrointestinal 8 CNS 7 Head & Neck 6 Endocrine 5 Sarcoma 4 Myeloid 4 Genitourinary 3 Breast 3 Tumor-Agnostic 2 Plasma cell 2 Other solid neoplasm 2 NET 2 Gynecologic 1

Conditions

Multiple Myeloma 2 Recurrence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03761108 2026-02-11

LINKER-MM1

Regeneron Pharmaceuticals

Phase 1/2 Recruiting

387 enrolled 1 FDA

Multiple Myeloma, Recurrence

NCT03548207 2025-07-30

CARTITUDE-1

Janssen Research & Development, LLC

Phase 1/2 Completed

126 enrolled 36 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡